Imavita is proud to announce the acquisition of new Optical Coherence Tomography apparatus to develop Innovating imaging of dermatology models.

Since september 2017, Imavita is working on this innovative imaging system (OQ Labscope / Lumedica) which will permit to generate non-invasive, surface tissue quantitative data for pre-clinical models in place at Imavita in Applications of interest, principally in the area of dermatology.OCT preclinical model Imavita

The benefits of this in vivo imaging modality are:

  • Easily and efficiently obtain calibrated quantitative data in preclinical models
  • Deepen understanding of disease mechanisms, disease progression and therapeutic responses
  • Manage costs and capture time course data by avoiding sacrifice of animal models

For more informations, do not hesitate to contact us.

Categories: News

About the Author

Eric Lacoste ()

Veterinary with experience in biomarkers / imaging of preclinical species Founder of the company Imavita

Website: https://imavita.com